the only thing that matters is whether the topline results are either GREAT (better than anything else out there or in development), or if the results are POOR. Until, then, NOBODY KNOWS! So, Ipix is now touting preclinical evidence in the event that the trial fails, they become a preclincal bunyanvirus company?
News 
Market Data 
Discover 
